Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females

By Duijkers Ingrid J.M.  

Human Reproduction, Vol. 17, Iss. 8, 2002-08 ,pp. : 1987-1993

Oxford University Press

Access to resources Recommend Favorite

Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis

By Coomarasamy Arri   Afnan Masoud   Cheema Deepti   van der Veen Fulco   Bossuyt Patrick M.M.   van Wely Madelon  

Human Reproduction, Vol. 23, Iss. 2, 2008-02 ,pp. : 310-315

Oxford University Press

Access to resources Recommend Favorite

Prospects for the Development of Long-Acting Formulations of Human Somatropin

By Jostel Andreas   Shalet Stephen M.  

Treatments in Endocrinology, Vol. 5, Iss. 3, 2006-01 ,pp. : 139-145

Adis International

Access to resources Recommend Favorite

Clinical Safety of Long-Acting β 2 -Agonist and Inhaled Corticosteroid Combination Therapy in COPD

By Decramer Marc   Ferguson Gary  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 3, Iss. 3, 2006-09 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Albiglutide: clinical overview of a long-acting GLP-1 receptor agonist in the treatment of Type 2 diabetes

By Setji Tracy   Feinglos Mark  

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 3, 2013-05 ,pp. : 229-238

Informa Healthcare

Access to resources Recommend Favorite